Phreesia, Inc. (PHR) — Analysis Summary
Phreesia, Inc. (PHR) has a market cap of $733.09M with year-over-year revenue growth of +11.4%. Net margin stands at 0.5%. The stock trades at a P/E ratio of 79.8.
Key Takeaways
- Revenue changed +11.4% year-over-year
- Net margin of 0.5%
- P/E ratio of 79.8
Compared to other companies in the SERVICES-BUSINESS SERVICES, NEC sector, PHR posted revenue growth of +11.4% and trades at a P/E of 79.8.
Phreesia, Inc. (PHR)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at 0.4x — earnings do not cover interest payments
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
Sector
SERVICES-BUSINESS SERVICES, NEC
Employees
1,789
Headquarters
WILMINGTON, DE
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.